SOBR SAFE INC (SOBR)       1.1614  -0.03 (-2.4%)

1.1614  -0.03 (-2.4%)

US8335922071 - Common Stock - After market: 1.16 0 (-0.12%)


Fundamental Rating

2

Overall SOBR gets a fundamental rating of 2 out of 10. We evaluated SOBR against 125 industry peers in the Electronic Equipment, Instruments & Components industry. SOBR scores bad on very profitability, while its financial health is fine. Not spectacular, but in line with the averages. SOBR is valued expensive and it does not seem to be growing.

Note: SOBR has only limited data available, so a full analysis was not possible, which makes the total rating unfair.




Profitability

Profitability Rating

1

The Piotroski-F score of SOBR is 4.00. This is a neutral score and indicates average health and profitability for SOBR.

VS Industry

Valuation

Valuation Rating

1

When comparing the current price to the book value of SOBR, we can conclude it is valued correctly. It is trading at 2.00 times its book value.
Compared to an average industry price book ratio of 1.92, SOBR is valued in line with its industry peers.

SOBR reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
VS Industry

Price/Book (2) VS Industry: 47% outperformed.

58.12
0.04

Growth

Growth Rating

2

Based on estimates for the next 5 years, SOBR will show a quite strong growth in Earnings Per Share. The EPS will grow by 19.54% on average per year.

SOBR shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -268.31%.

PastFuture
5Y3Y1Y1Y2Y3Y5Y
EPSN/A N/A -268.31% N/A N/A 19.54% N/A
RevenueN/A N/A N/A N/A N/A N/A N/A

Health

Health Rating

4

SOBR has a Current Ratio of 3.00. This indicates that SOBR is financially healthy and has no problem in meeting its short term obligations.
SOBR has a Quick Ratio of 2.91. This indicates that SOBR is financially healthy and has no problem in meeting its short term obligations.
When comparing the Quick Ratio to an average industry Quick Ratio of 1.67, SOBR is better placed than the average industry peer to meet its short term obligations.
When comparing the Debt to Equity Ratio of 0.00 to an average industry Debt to Equity of 0.12, SOBR is way less dependent on financing that its industry peers.

The Current Ratio is in line with the industry averages, which is at 2.54.
SOBR has a Piotroski-F score of 4.00. This indicates an average health and profitability for SOBR.
SOBR has an Altman-Z score of -7.65. This is a bad value and indicates that SOBR is not financially healthy and even has some risk of bankruptcy.
Compared to an average industry Altman-Z score of 2.76, SOBR is in worse financial state than most of its industry peers. 98% of its industry peers have a better Altman-Z score.
VS Industry

Debt/Equity (0) VS Industry: 73% outperformed.

22.40
0.00

Quick Ratio (2.91) VS Industry: 70% outperformed.

0.03
26.42

Current Ratio (3) VS Industry: 60% outperformed.

0.03
27.20

Altman-Z (-7.65) VS Industry: 2% outperformed.

-2,008.72
300.49

Dividend

Dividend Rating

0

SOBR does not give a dividend.

SOBR SAFE INC1.1614

NASDAQ:SOBR (1/27/2023, 7:00:03 PM)-0.03 (-2.4%)

After market: 1.16 0 (-0.12%)

Chartmill FA Rating
GICS Sector Information Technology
GICS IndustryGroup Technology Hardware & Equipment
GICS Industry Electronic Equipment, Instruments & Components
Earnings (Last) N/A N/A Earnings (Next) 03-09 2023-03-09
Inst Owners N/A Inst Owner Change N/A
Ins Owners 2.74% Ins Owner Change 0%
Market Cap 16.92M Analysts N/A
Price Target N/A

Dividend
Dividend Yield N/A Dividend Growth N/A
DP N/A Ex-Date N/A

Surprises & Revisions
EPS beat(2) N/A Avg EPS beat(2) N/A
Min EPS beat(2) N/A Max EPS beat(2) N/A
EPS beat(4) N/A Avg EPS beat(4) N/A
Min EPS beat(4) N/A Max EPS beat(4) N/A
Revenue beat(2) N/A Avg Revenue beat(2) N/A
Min Revenue beat(2) N/A Max Revenue beat(2) N/A
Revenue beat(4) N/A Avg Revenue beat(4) N/A
Min Revenue beat(4) N/A Max Revenue beat(4) N/A
PT rev (1m) N/A EPS NQ rev (1m) 0%
EPS NY rev (1m) N/A Revenue NQ rev (1m) 0%
Revenue NY rev (1m) N/A

Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1329.37
P/FCF N/A
P/OCF N/A
P/B 2
P/tB 3.08
EV/EBITDA N/A
EPS(TTM) -2.11 EY N/A
EPS(NY) N/A Fwd EY N/A
FCF(TTM) -0.39 FCFY N/A
OCF(TTM) -0.39 OCFY N/A
SpS 0 BVpS 0.58
TBVpS 0.38 PEG (NY) N/A
PEG (5Y) N/A

Profitability
Industry RankSector Rank
ROA N/A
ROE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM N/A
GM N/A
ROICexgc(3y) N/A ROICexcg growth 3Y N/A
ROICexcg growth 5Y N/A ROICexc(3y) N/A
ROICexc growth 3Y N/A ROICexc growth 5Y N/A
OM growth 3Y N/A OM growth 5Y N/A
PM growth 3Y N/A PM growth 5Y N/A
GM growth 3Y N/A GM growth 5Y N/A
F-Score 4 Asset Turnover 0

Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Profit Quality N/A
Current Ratio 3
Quick Ratio 2.91
Altman-Z -7.65
F-Score 4 WACC N/A
ROIC/WACC N/A Cap/Depr(3y) N/A
Cap/Depr(5y) N/A Profit Quality(3y) N/A
Profit Quality(5y) N/A

Growth
EPS 1Y -268.31% EPS 3Y N/A
EPS 5Y N/A EPS growth Q2Q -352.88%
EPS Next Y N/A EPS Next 2Y N/A
EPS Next 3Y 19.54% EPS Next 5Y N/A
Revenue growth 1Y N/A Revenue growth 3Y N/A
Revenue growth 5Y N/A Revenue growth Q2Q N/A
Revenue Next Year N/A Revenue Next 2Y N/A
Revenue Next 3Y N/A Revenue Next 5Y N/A
EBIT growth 1Y -76.47% EBIT growth 3Y N/A
EBIT growth 5Y N/A EBIT Next Year N/A
EBIT Next 3Y 5.38% EBIT Next 5Y N/A
FCF growth 1Y -217.87% FCF growth 3Y N/A
FCF growth 5Y N/A OCF growth 1Y -217.87%
OCF growth 3Y N/A OCF growth 5Y N/A

Fundamental Stock Screener Links

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA